Introduction

A discussion on the skepticism surrounding ozempic, a diabetes drug claiming to aid in weight loss, and the underlying metabolic dysfunction caused by environmental factors contributing to the obesity epidemic. The speaker criticizes the pharmaceutical industry's profit-driven approach and emphasizes the need to address the corrupt practices in the food industry and government subsidies.